Tag Archives: What’s

Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?

Sales of Merck & Co.’s immuno-oncology heavy hitter Keytruda soared 66% in the fourth quarter to $ 2.15 billion, surpassing Wall Street’s expectations yet again. But Merck can’t rely solely on one blockbuster’s dutiful performance to drive sales and earnings growth going forward. Analysts’ worries about that fact only intensified on Friday after Merck put… Read More »

What’s Behind the CDC Claiming 80,000 Died From Flu Last Winter?

By Dr. Mercola According to the U.S. Centers for Disease Control and Prevention (CDC), the 2017-2018 flu season was the deadliest flu season in the U.S. in four decades, hospitalizing 900,000 and killing 80,000, including 180 children. According to CNN,1 “ … [F]lu-related deaths have ranged from a low of about 12,000 during the 2011-2012… Read More »